187 related articles for article (PubMed ID: 24532795)
21. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
22. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation.
Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J
Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608
[TBL] [Abstract][Full Text] [Related]
23. The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis.
Mahmoudi T; Boj SF; Hatzis P; Li VS; Taouatas N; Vries RG; Teunissen H; Begthel H; Korving J; Mohammed S; Heck AJ; Clevers H
PLoS Biol; 2010 Nov; 8(11):e1000539. PubMed ID: 21103407
[TBL] [Abstract][Full Text] [Related]
24. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
25. A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis.
Wang W; Liu H; Wang S; Hao X; Li L
Cell Res; 2011 May; 21(5):730-40. PubMed ID: 21321609
[TBL] [Abstract][Full Text] [Related]
26. SUMO-1 regulates the conformational dynamics of thymine-DNA Glycosylase regulatory domain and competes with its DNA binding activity.
Smet-Nocca C; Wieruszeski JM; Léger H; Eilebrecht S; Benecke A
BMC Biochem; 2011 Feb; 12():4. PubMed ID: 21284855
[TBL] [Abstract][Full Text] [Related]
27. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer.
Yang X; Pan Q; Lu Y; Jiang X; Zhang S; Wu J
Cell Biol Int; 2019 Apr; 43(4):402-408. PubMed ID: 30614606
[TBL] [Abstract][Full Text] [Related]
28. MENA is a transcriptional target of the Wnt/beta-catenin pathway.
Najafov A; Seker T; Even I; Hoxhaj G; Selvi O; Ozel DE; Koman A; Birgül-İyison N
PLoS One; 2012; 7(5):e37013. PubMed ID: 22615875
[TBL] [Abstract][Full Text] [Related]
29. p15RS attenuates Wnt/{beta}-catenin signaling by disrupting {beta}-catenin·TCF4 Interaction.
Wu Y; Zhang Y; Zhang H; Yang X; Wang Y; Ren F; Liu H; Zhai Y; Jia B; Yu J; Chang Z
J Biol Chem; 2010 Nov; 285(45):34621-31. PubMed ID: 20739273
[TBL] [Abstract][Full Text] [Related]
30. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells.
Ju X; Ishikawa TO; Naka K; Ito K; Ito Y; Oshima M
Cancer Sci; 2014 Apr; 105(4):418-24. PubMed ID: 24447505
[TBL] [Abstract][Full Text] [Related]
31. SUMO-1-dependent allosteric regulation of thymine DNA glycosylase alters subnuclear localization and CBP/p300 recruitment.
Mohan RD; Rao A; Gagliardi J; Tini M
Mol Cell Biol; 2007 Jan; 27(1):229-43. PubMed ID: 17060459
[TBL] [Abstract][Full Text] [Related]
32. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin.
Evans PM; Chen X; Zhang W; Liu C
Mol Cell Biol; 2010 Jan; 30(2):372-81. PubMed ID: 19901072
[TBL] [Abstract][Full Text] [Related]
33. Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis.
Jiang S; Li Q; Liu Y; Zhang H; Wang Q; Chen Y; Shi X; Li J; Zhang H; Zhang Y; Xia D; Wu M; Lin J; Zhang C; Pang S; Jiang J; Wen Y; Zhang P
BMC Cancer; 2021 Feb; 21(1):180. PubMed ID: 33607955
[TBL] [Abstract][Full Text] [Related]
34. T:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motif.
Lucey MJ; Chen D; Lopez-Garcia J; Hart SM; Phoenix F; Al-Jehani R; Alao JP; White R; Kindle KB; Losson R; Chambon P; Parker MG; Schär P; Heery DM; Buluwela L; Ali S
Nucleic Acids Res; 2005; 33(19):6393-404. PubMed ID: 16282588
[TBL] [Abstract][Full Text] [Related]
35. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
36. Defining the impact of sumoylation on substrate binding and catalysis by thymine DNA glycosylase.
Coey CT; Drohat AC
Nucleic Acids Res; 2018 Jun; 46(10):5159-5170. PubMed ID: 29660017
[TBL] [Abstract][Full Text] [Related]
37. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
38. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
39. SUMO-modification and elimination of the active DNA demethylation enzyme TDG in cultured human cells.
Moriyama T; Fujimitsu Y; Yoshikai Y; Sasano T; Yamada K; Murakami M; Urano T; Sugasawa K; Saitoh H
Biochem Biophys Res Commun; 2014 May; 447(3):419-24. PubMed ID: 24727457
[TBL] [Abstract][Full Text] [Related]
40. The kinase TNIK is an essential activator of Wnt target genes.
Mahmoudi T; Li VS; Ng SS; Taouatas N; Vries RG; Mohammed S; Heck AJ; Clevers H
EMBO J; 2009 Nov; 28(21):3329-40. PubMed ID: 19816403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
